← Back
Data updated: Mar 10, 2026
ASCOT
CardiovascularNeurologyOphthalmology
ASCOT is a generic drug manufacturer focused on Cardiovascular, Neurology, Ophthalmology.
1983
Since
18
Drugs
-
Trials
53
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ACETAZOLAMIDE 2026-01-12
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2025-11-25
Manufacturing (CMC)
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 2025-09-19
Manufacturing (CMC)
ACETAZOLAMIDE 2025-09-16
Labeling
ACETAZOLAMIDE 2025-09-16
Labeling
SPIRONOLACTONE 2025-07-25
HYDRALAZINE HYDROCHLORIDE 2025-07-17
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 40%
2 drugs
Neurology 20%
1 drugs
Ophthalmology 20%
1 drugs
Gastroenterology 20%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
BAUSCH specialty
Ophthalmology, Cardiovascular, Gastroenterology
Novartis big-pharma
Cardiovascular, Ophthalmology
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Ophthalmology
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology
Active (2)
Discontinued (16)
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE SPIRONOLACTONE HYDRALAZINE HYDROCHLORIDE METHOCARBAMOL PROCAINAMIDE HYDROCHLORIDE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE CHLORTHALIDONE ORPHENADRINE CITRATE AMINOPHYLLINE QUINIDINE GLUCONATE CHLORDIAZEPOXIDE HYDROCHLORIDE CYPROHEPTADINE HYDROCHLORIDE BETHANECHOL CHLORIDE TOLBUTAMIDE PROPANTHELINE BROMIDE SULFAMETHOXAZOLE
Company Info
- First Approval
- 1983-05-18
- Latest
- 1984-12-17
- Applications
- 28